Download:
pdf |
pdfHuman Research Protection Program
Institutional Review Boards
FWA00002571
25 Science Park – 3rd Fl., 150 Munson St.
New Haven CT 06520-8327
Telephone: 203-785-4688
http://www.yale.edu/hrpp
February 28, 2023
EXEMPTION DETERMINATION
Determination Date: 2/2/2023
Investigator:
Type of Review:
Title of Study:
Jennifer Miller
Initial Study
EXEMPT: A positive deviance approach for representing
women, older adults and patients identifying as racial and ethnic
minorities in oncology research
IRB Protocol ID:
Submission ID:
Documents:
2000033803
2000033803
• COVID Supplement, Category: Other;
• Demographic Survey, Category: Study questionnaires,
measures, focus groups/interview questions;
• Exemption Form , Category: IRB Protocol;
• Interview Guide, Category: Study questionnaires, measures,
focus groups/interview questions;
• Recruitment Email , Category: Recruitment Materials;
• Updated Consent Forms Clean, Category: Consent Form;
This research was deemed exempt under Exempt Category 45 CFR
46.104(d)(2)(ii).
The protocol does not require annual IRB review.
See the next page for important reminders.
Page 1 of 2
Human Research Protection Program
Institutional Review Boards
FWA00002571
25 Science Park – 3rd Fl., 150 Munson St.
New Haven CT 06520-8327
Telephone: 203-785-4688
http://www.yale.edu/hrpp
IMPORTANT REMINDERS:
Exempt research does not require additional IRB oversight except in cases where
the study is to be modified in a way that would change the applicability of the exempt
status.
Should you wish to modify the study in way that affects the applicability of the
exemption determination, a new protocol must be submitted for the IRB review. See
IRB Guidance document 100 GD 9: Guidance on Exemption from IRB Review for
examples.
Information that requires prompt reporting to the IRB must be done so within 5 days
of the PI becoming aware of the event (see Policy 710: Reporting Unanticipated
Problems Involving Risks to Subjects or Others, including Adverse Events). This
includes potential serious noncompliance, continuing noncompliance, and
unanticipated problems to subjects or others.
In conducting this activity, you should refer to and follow the Investigator Manual
(HRP-103) as applicable, which can be found in the IRB Library within the IRB
system.
Please keep this letter with your copy of the protocol documents.
Page 2 of 2
File Type | application/pdf |
File Title | TEMPLATE LETTER: Approval of Protocol |
Subject | Huron HRPP ToolKit |
Author | Jeffrey A. Cooper, MD, MMM |
File Modified | 2023-06-21 |
File Created | 2018-07-12 |